Dulaglutide is marketed by Eli Lilly under the brand name Trulicity for the treatment of type 2 diabetes and is registered for this use in South Africa. It is marketed by Aspen through a ...

Mary Lynne Hedley, Board Member at Eli Lilly (NYSE:LLY), reported an insider buy on November 20, according to a new SEC filing. What Happened: Hedley's recent purchase of 315 shares of Eli Lilly ...

Eli Lilly and Company (NYSE:LLY) Q3 2024 Earnings Call Transcript October 30, 2024 Eli Lilly and Company misses on earnings expectations. Reported EPS is $1.18 EPS, expectations were $1.47 ...

Among some of Lilly's other bigger sellers, sales of diabetes treatment Trulicity dropped 22.2% to $1.3 billion, as "competitive dynamics" offset higher prices, but that topped expectations of $1. ...

Trulicity, which is used in people with type 2 diabetes, can cause certain side effects. Learn about its mild and serious side effects and how to manage them.

The Lilly Cares Foundation may also offer a Patient Assistance Program. You can learn about this program by visiting the Foundation website or by calling 800-545-6962.

Eli Lilly and Company (NYSE: LLY) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Company Participants Kevin Hern - Vice President of Investor Relations Dave Ricks - Chair & Chief ...

INDIANAPOLIS, June 4, 2022 /PRNewswire/ -- In the phase 3 AWARD-PEDS clinical trial from Eli Lilly and Company (NYSE: LLY), Trulicity ® (dulaglutide) (at 0.75 mg and 1.5 mg doses) led to superior ...